Latest News

Buffalo Business First reported that UB spinout company POP Biotechnologies, founded by Jonathan Lovell, will receive up to nearly $10 million to advance a vaccine candidate for the bird flu and help prepare for any future pathogen outbreak. 

Series B also profiled UB spinout startup company QAS.AI, cofounded by Ciprian Ionita, which is working to help doctors make better decisions during surgery through AI.

UB spinout company POP Biotechnologies, co-founded by Jonathan Lovell, will receive nearly $10 million to advance a rapid-response vaccine platform. 

Funding will help Buffalo-based company advance a bird flu vaccine candidate and test its vaccine platform for future outbreak response.

First Word Pharma reported that UB spinout company POP Biotechnologies, co-founded by Jonathan Lovell, has received $9.7 million to continue development of its nanoparticle vaccine platform. 

The 2026 cohort of CTSI K Scholars features faculty from the University at Buffalo and Roswell Park Comprehensive Cancer Center.

The School of Engineering and Applied Sciences ranked No. 55 nationwide and No. 30 among public universities in U.S. News & World Report’s Best Graduate School Rankings 

Blue Ridge Institute for Medical Research rankings measure schools of medicine across the country, as well as their departments and other health sciences schools, such as dentistry, pharmacy, public health and nursing.